U.S. flag

An official website of the United States government

NM_001358921.2(COQ2):c.138dup (p.Ala47fs) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 7, 2022
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003151146.2

Allele description [Variation Report for NM_001358921.2(COQ2):c.138dup (p.Ala47fs)]

NM_001358921.2(COQ2):c.138dup (p.Ala47fs)

Genes:
LOC112997540:Sharpr-MPRA regulatory region 13773 [Gene]
COQ2:coenzyme Q2, polyprenyltransferase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
4q21.23
Genomic location:
Preferred name:
NM_001358921.2(COQ2):c.138dup (p.Ala47fs)
Other names:
p.Ala97Argfs*56
HGVS:
  • NC_000004.12:g.83284632dup
  • NG_015825.1:g.5288dup
  • NG_061533.1:g.97dup
  • NM_001358921.2:c.138dupMANE SELECT
  • NM_015697.8:c.288dup
  • NM_015697.9:c.288dup
  • NP_001345850.1:p.Ala47fs
  • NP_056512.5:p.Ala97fs
  • NC_000004.11:g.84205779_84205780insG
  • NC_000004.11:g.84205785dup
  • NM_015697.7:c.288dup
  • NM_015697.7:c.288dupC
Protein change:
A47fs
Links:
dbSNP: rs759310292
NCBI 1000 Genomes Browser:
rs759310292
Molecular consequence:
  • NM_001358921.2:c.138dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_015697.9:c.288dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003839370Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Uncertain significance
(Mar 7, 2022)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV003839370.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

DNA sequence analysis of the COQ2 gene demonstrated a one base pair duplication in exon 1, c.288dup. This duplication results in an amino acid frameshift and is predicted to create a premature stop codon 56 amino acids downstream of the change, p.Ala97Argfs*56. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated COQ2 protein with potentially abnormal function. However, there are multiple in-frame methionines in exon 1 of the COQ2 gene, and experimental studies have demonstrated that alternate methionines may be used as the initiation codon (PMID: 27493029). This sequence change has been described in the gnomAD database with a frequency of 0.37% in the Ashkenazi Jewish subpopulation (dbSNP rs759310292). This duplication has been previously described in the compound heterozygous state with a missense variant in a family of Ashkenazi Jewish ancestry with nephropathy and retinopathy, but without neurological involvement (PMID: 33187544). The functional significance of this sequence change is not known at present and its contribution to this individual's disease phenotype cannot definitively be determined.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024